Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Regulatory News (HAYD)

Share Price Information for Haydale (HAYD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.46
Bid: 0.45
Ask: 0.47
Change: 0.00 (0.00%)
Spread: 0.02 (4.444%)
Open: 0.46
High: 0.46
Low: 0.46
Prev. Close: 0.46
HAYD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealing

1 Dec 2015 12:05

RNS Number : 5744H
Haydale Graphene Industries PLC
01 December 2015
 

Haydale Graphene Industries plc

("Haydale" or the "Company")

 

Director Dealing

 

 

Haydale (AIM: HAYD), the group focused on the commercialisation of graphene and other nano particle products using its proprietary plasma process, announces that, on 1 December 2015, Ray Gibbs, Chief Executive, made the following transactions:

 

1. Exercise of 40,500 options under the 2013 Share Option Scheme to subscribe for a total of 40,500 ordinary shares of 2 pence each in the Company ("Ordinary Shares") at an exercise price of 92.5926 pence per share; and

 

2. Sale of 40,500 Ordinary Shares, at a price of 170.5 pence per share.

 

The sale proceeds will be used to fund, in part, the subscription of new shares by Ray Gibbs as outlined in the announcement on 2 November 2015.

 

Following the exercise of these options and disposal of shares, Mr. Gibbs' interest in the Company will remain unchanged at 469,929 Ordinary Shares representing 3.08% of the issued share capital of the Company.

 

Application has been made for the 40,500 Ordinary Shares to be admitted to trading on AIM and trading of these shares is expected to commence on or around 2 December 2015 ("Admission").

 

Following Admission, the Company has 15,236,946 Ordinary Shares in issue. The figure of 15,236,946 Ordinary Shares may be used by shareholders of Haydale as the denominator for the calculations to determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

- Ends -

 

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman, Will Goode (Corporate Finance)

David Banks, Tessa Sillars (Corporate Broking)

 

Hermes Financial PR

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale (www.haydale.com)

Haydale has developed a patent pending proprietary scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a low pressure plasma process that treats both organic mined fine powder and other synthetically produced nanomaterial powders producing high quality few layered graphenes and graphene nano platelets. The process can functionalise with a range of chemical groups, where the amount of chemicals can be tailored to the customer needs. Good dispersion improves the properties and performance of the host material and ensures it delivers as specified.

The Haydale plasma process does not use wet chemistry, neither does it damage the material being processed, rather it can clean up impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale method is an enabling technology where working with a raw material producer can add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales, housed in a purpose built facility for processing and handling nanomaterials with a laboratory facility, is facilitating the application of graphenes and other nanomaterials in fields such as inks, sensors, energy storage, photovoltaics, composites, paints and coatings.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSBDBDDSGGBGUB
Date   Source Headline
23rd Dec 20167:00 amRNSIssue of Shares
15th Dec 20163:00 pmRNSResult of AGM
15th Dec 20167:00 amRNSAGM Statement
28th Nov 20167:00 amRNSAgreement with Huntsman Advanced Materials
22nd Nov 20167:00 amRNSAnnual Financial Report
19th Oct 20167:00 amRNSPDMR Dealings
18th Oct 20167:00 amRNSPDMR Dealings
17th Oct 20167:00 amRNSGrant of Options
13th Oct 20167:00 amRNSPDMR Dealings
13th Oct 20167:00 amRNSDistribution Agreement
11th Oct 20167:00 amRNSResult of Open Offer and Total Voting Rights
28th Sep 20167:00 amRNSContract Extension
23rd Sep 201610:57 amRNSResult of Placing
23rd Sep 20167:01 amRNSFinal Results
23rd Sep 20167:00 amRNSProposed Acquisition and Fundraise
9th Sep 20164:05 pmRNSCompletion of Innophene Acquisition
26th Aug 20167:00 amRNSDirector/PDMR Shareholding
25th Aug 20167:00 amRNSAcquisition and Issue of Equity
11th Aug 20167:00 amRNSGraphene Enhanced PLA Filaments for 3D Printing
8th Aug 20167:00 amRNSHaydale Funds New Professorial Chair Within WCPC
29th Jul 20167:00 amRNSBoard Change
7th Jun 201610:42 amRNSGrant of Warrants
26th May 20167:00 amRNSAgreement with Flowtite Technology AS
20th May 20163:27 pmRNSDirector Dealing
20th May 20167:00 amRNSGrant of Options
18th May 20167:00 amRNSReactor Supply and Collaboration Agreement
9th May 20167:00 amRNSInvestor Open Day
25th Apr 20164:40 pmRNSHolding(s) in Company
7th Apr 201611:28 amRNSCorrection: Joint Development & Supply Agreement
7th Apr 20167:00 amRNSJoint Development and Supply Agreement
22nd Mar 20167:00 amRNSHalf Yearly Report
14th Mar 20167:00 amRNSGraphene Enhanced Composite Products Launched
8th Mar 201611:12 amRNSNotice of Results
16th Feb 20167:00 amRNSGrant Awards
4th Feb 20167:00 amRNSHaydale Commission Composite Pipe Testing Facility
3rd Feb 20167:00 amRNSAcquisition of Rights and Grant of Warrants
3rd Dec 201511:58 amRNSResult of AGM
1st Dec 201512:05 pmRNSDirector Dealing
26th Nov 20157:00 amRNSHolding(s) in Company
25th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 201510:50 amRNSResults of General Meeting
20th Nov 20151:14 pmRNSResult of Open Offer
17th Nov 20157:00 amRNSGrant Awards
10th Nov 201511:32 amRNSNotice of AGM
6th Nov 20154:45 pmRNSPosting of Open Offer Application Forms
2nd Nov 201512:50 pmRNSDirector/PDMR Shareholding
2nd Nov 20157:01 amRNSIssue of Equity
2nd Nov 20157:00 amRNSFinal Results
14th Oct 20157:00 amRNSEuropean Patent Grant
1st Oct 20157:00 amRNSAgreement with Scott Bader Company Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.